Wegovy-maker Novo Nordisk starts ‘fight back’ as investors return

view original post

Novo Nordisk’s shares rose by 5.4% on Thursday as investors turned more positive about the Danish drugmaker’s prospects following a key diabetes conference held in Vienna this week.